REG - Fortis Frontier PLC - Result of General Meeting

Fortis FrontierAnnouncement

28/04/2026 11:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260428:nRSb2327Ca&default-theme=true

RNS Number : 2327C  Fortis Frontier PLC  28 April 2026

 

Fortis Frontier PLC

("Fortis Frontier" or the "Company")

 

Result of General Meeting

 

Fortis Frontier PLC (AIM: FORF), an AIM Rule 15 cash shell (formerly
MyHealthChecked PLC), announces that at general meeting held earlier today
both resolutions were passed.

 

As such the EIS Buyback Agreement and the GP Buyback Agreement, to purchase,
in aggregate, 13,717,619 Ordinary Shares from Mercia, as notified in the
Company's announcement of 1 April 2026, are expected to complete shortly. The
Buyback Shares will be cancelled.

 

 Resolution                                            For        % For   Against  % Against  Withheld
 1. To approve the terms of the EIS Buyback Agreement  8,581,297  98.47%  132,980  1.53%      9,728
 2. To approve the terms of the GP Buyback Agreement   8,581,297  98.47%  132,980  1.53%      9,728

 

 

Total Voting Rights

Following cancellation, the Company's issued ordinary share capital will
consist of 36,148,766 Ordinary Shares, with one vote per share. As the Company
does not hold any Ordinary Shares in treasury this figure may be used by
shareholders in the Company as the denominator for the calculations by which
they will determine if they are required to notify their interest in, or a
change to their interest in, the share capital of the Company under the FCA's
Disclosure Guidance and Transparency Rules.

 

Unless otherwise defined, all definitions used in this announcement will have
the same meaning as described in the Circular dated 1 April 2026.

 

For further information contact:

 

 Fortis Frontier PLC                          www.fortisfrontierplc-ir.com (http://www.fortisfrontierplc-ir.com)
 Adam Reynolds, Executive Chairman            via Walbrook PR

 SPARK Advisory Partners Limited (NOMAD)      Tel: +44 (0)20 3368 3550
 Neil Baldwin / Dillon Wall

 Singer Capital Markets (Broker)              Tel: +44 (0)20 7496 3000
 James Serjeant / Russell Cook / Amber Higgs

 Walbrook PR Ltd (Media & IR)                 Tel: +44 (0)20 7933 8780 or fortisfrontier@walbrookpr.com
                                              (mailto:fortisfrontier@walbrookpr.com)
 Paul McManus / Alice Woodings                Mob: +44 (0)7980 541 893 / +44(0)7407 804 654

 

About Fortis Frontier PLC

On 10 November 2025 MyHealthChecked PLC completed the disposal of its trading
subsidiary, Concepta Diagnostics Limited, becoming an AIM Rule 15 Cash Shell,
as defined in the AIM Rules for Companies. On the same day the Company changed
its name to Fortis Frontier PLC. The Board is now carefully considering the
strategic options available to it in order to maximise shareholder value.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  ROMFIFSASTITFIR



            Copyright 2019 Regulatory News Service, all rights reserved